Advanced Cancer
Showing NaN - NaN of 40
Advanced Cancer, Pain Trial in Boston (I-STAMP)
Not yet recruiting
- Advanced Cancer
- Pain
- I-STAMP
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 31, 2023
Opioid-Related Disorders, Pain Management, Pain Management and Care Trial in Boston (Psilocybin)
Not yet recruiting
- Opioid-Related Disorders
- +4 more
-
Boston, Massachusetts
- +2 more
Aug 14, 2023
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Active Cancer, Active Cancer Treatment, Advanced Cancer Trial in Boston, Methuen, Londonderry (STAMP+CBT application)
Recruiting
- Active Cancer
- +4 more
- STAMP+CBT application
-
Boston, Massachusetts
- +2 more
Nov 17, 2022
Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)
Recruiting
- Advanced Cancer
- +7 more
-
Scottsdale, Arizona
- +14 more
Sep 15, 2022
Advanced Cancer Trial in Boston (Hospice Video Educational Tool, Standard of Care)
Completed
- Advanced Cancer
- Hospice Video Educational Tool
- Standard of Care
-
Boston, MassachusettsMassachusetts general Hospital
Aug 28, 2022
Advanced Cancer, End Stage Organ Failure Trial in United States (Nurse-led telephonic case management, Facilitated,outpatient
Active, not recruiting
- Advanced Cancer
- End Stage Organ Failure
- Nurse-led telephonic case management
- Facilitated,outpatient specialty palliative care
-
Los Angeles, California
- +17 more
Aug 16, 2022
Metastatic Cancer, Solid Tumor, Advanced Cancer Trial in Korea, Republic of, United States (Evorpacept (ALX148), Pembrolizumab,
Active, not recruiting
- Metastatic Cancer
- +3 more
- Evorpacept (ALX148)
- +5 more
-
Denver, Colorado
- +9 more
Jul 20, 2022
Advanced Cancer Trial in Boston (ACP video decision aid, Usual Care-)
Completed
- Advanced Cancer
- ACP video decision aid
- Usual Care-
-
Boston, Massachusetts
- +2 more
May 31, 2022
Pancreatic Cancer, Advanced Cancer Trial in Boston, Chapel Hill (Hydroxychloroquine Sulfate, LY3214996)
Recruiting
- Pancreatic Cancer
- Advanced Cancer
- Hydroxychloroquine Sulfate
- LY3214996
-
Boston, Massachusetts
- +2 more
Apr 6, 2022
Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cancer Trial in United States (CMP-001, cemiplimab-rwlc)
Recruiting
- Merkel Cell Carcinoma
- +4 more
-
Jacksonville, Florida
- +6 more
Feb 24, 2022
Advanced Cancer Trial in Worldwide (Ipilimumab, BMS-986218, Nivolumab)
Recruiting
- Advanced Cancer
- Ipilimumab
- +2 more
-
Aurora, Colorado
- +55 more
Mar 7, 2022
Differentiated Thyroid Cancer, Advanced Cancer Trial in Boston (LENVATINIB)
Recruiting
- Differentiated Thyroid Cancer
- Advanced Cancer
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 3, 2022
Cancer, Follow-Up Care, Consultation, Remote Trial in Boston (CONTINUUM Intervention, Usual Care)
Recruiting
- Cancer
- +3 more
- CONTINUUM Intervention
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 10, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Advanced Cancer, Home Care, Hospital-Based Trial in Boston (CONTINUity of care Under Management by Video visits (CONTINUUM-V))
Completed
- Advanced Cancer
- Home Care, Hospital-Based
- CONTINUity of care Under Management by Video visits (CONTINUUM-V)
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Nov 11, 2021
Advanced Cancer Trial in Santa Monica, Boston, San Antonio (LY2835219, Fulvestrant)
Active, not recruiting
- Advanced Cancer
-
Santa Monica, California
- +2 more
Oct 4, 2021
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer Trial in United States (MPT-0118, MPT-0118 + pembrolizumab)
Recruiting
- Solid Tumor, Adult
- +4 more
- MPT-0118
- MPT-0118 + pembrolizumab
-
Santa Monica, California
- +4 more
Sep 15, 2021
Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)
Active, not recruiting
- Advanced Cancer
- +3 more
- LY3214996
- +6 more
-
Washington, District of Columbia
- +12 more
Sep 2, 2021